John Pullman

2.8k citations
25 papers · 1.1k · 1 hit paper · h-index 13

Impact in

Papers in

    • Antimicrobial Resistance in Staphylococcus 7
    • Clostridium difficile and Clostridium perfringens research 4
    • Antifungal resistance and susceptibility 3
    • Pneumonia and Respiratory Infections 4

John Pullman

24 papers receiving 1.0k citations

John Pullman's Hit Papers

DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes 2011 · 381 citations
3810+5+10Years since publication100200300

Peers

John Pullman
Comparison fields: 5 of 72
  • Endocrinology, Diabetes and Metabolism 433
  • Infectious Diseases 283
  • Molecular Medicine 77
  • Clinical Biochemistry 92
  • Applied Microbiology and Biotechnology 25
Replace Ismail Mitha with:
Ismail Mitha United Kingdom
Anna K. Poon United States
Saroj Khatiwada Nepal
Pilar Luqué Spain
Gye Cheol Kwon South Korea
Partha Bagchi United States
Marco Fiore Italy
Frederick J. Buckwold Canada
Jan Pachl Czechia
Marise Auxiliadora de Barros Reis Brazil
John Pullman relative to Ismail Mitha United Kingdom Ismail Mitha's profile →
Citations per field
00.5×
Ismail Mitha · 1×
Citations per year

Countries citing papers authored by John Pullman

Since Specialization
Citations

This map shows the geographic impact of John Pullman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Pullman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Pullman more than expected).

Fields of papers citing papers by John Pullman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Pullman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Pullman. The network helps show where John Pullman may publish in the future.

Co-authors

The 25 scholars most cited alongside John Pullman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Pullman Line = papers co-authored together John Pullman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes
Hit paper breakdown →
2011381
2 2005108
3 201788
4 201567
5 199866
6 200760
7 201459
8 201952
9 200646
10 200344
11 200322
12 201822
13 201613
14 199611
15 202310
16 20159
17 20198
18 20247
19
Abstract 12074: A Randomized, Open-Label, Multicenter Study of the Efficacy and Safety of Edoxaban Monotherapy versus Low-Molecular Weight Heparin/Warfarin in Patients With Symptomatic Deep Vein Thrombosis - Edoxaban Thrombus Reduction Imaging Study (eTRIS)
20144
20 20192

About John Pullman

John Pullman is a scholar working on Infectious Diseases, Epidemiology, Microbiology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Infections and Vaccines (4 papers), Pneumonia and Respiratory Infections (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Antifungal resistance and susceptibility (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Streptococcal Infections and Treatments (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (433 citations), Infectious Diseases (283 citations), Molecular Medicine (77 citations), Clinical Biochemistry (92 citations) and Applied Microbiology and Biotechnology (25 citations). John Pullman has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Jaret Malloy, Christine T. Schulteis, Lisa A. Porter, Kristin Taylor, Michael Trautmann, Ping Yan, Thomas Blevins, Laura Lawrence, Sue Cammarata and Juan P. Frías. Their work appears in journals such as Open Forum Infectious Diseases, Journal of Antimicrobial Chemotherapy, Infection and Immunity, The Lancet Infectious Diseases and Respiratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact